{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T14:14:28Z","timestamp":1777126468808,"version":"3.51.4"},"reference-count":57,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"unspecified","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"the Key Project of Tianjin Natural Science Foundation","award":["21JCZDJC01080"],"award-info":[{"award-number":["21JCZDJC01080"]}]},{"name":"Academic Backbone of \u201cClinical Talent Training and Climbing Plan\u201d of Tianjin Medical University"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,4,24]]},"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To develop and validate a risk prediction model for adverse outcomes in patients with angina with non-obstructive coronary arteries (ANOCA) confirmed by invasive coronary angiography.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>A tertiary cardiovascular care centre in China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>From 17 816 consecutive patients undergoing coronary angiography for suspected coronary artery disease, 5934 met ANOCA criteria after rigorous exclusion: (1) significant stenosis (\u226550% luminal narrowing), (2) established coronary artery disease history, (3) incomplete baseline\/follow-up data, (4) non-cardiovascular life-limiting conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcome measures<\/jats:title>\n                    <jats:p>The primary outcome was a composite of all-cause death, non-fatal myocardial infarction (MI), stroke and repeat percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). The secondary outcome was major adverse cardiovascular events, defined as cardiac-related death, non-fatal MI, non-fatal stroke, repeat PCI and CABG.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The derivation cohort (n=4452) and validation cohort (n=1482) demonstrated comparable baseline characteristics. The nomogram incorporated eight prognosticators: age, haemoglobin, serum urea, serum sodium, alanine aminotransferase\/aspartate aminotransferase ratio, N-terminal pro-B-type natriuretic peptide (NT-proBNP), left atrial diameter and left ventricular ejection fraction. The prediction model showed robust discrimination for primary endpoint, achieving area under the curve (AUC) values of 0.82 (1\u2009year), 0.90 (2\u2009years) and 0.89 (3\u2009years) in the derivation cohort, with corresponding validation cohort AUCs of 0.75, 0.77 and 0.78. Calibration plots revealed close alignment between predicted and actual event-free survival probabilities in both cohorts. Risk stratification identified two distinct prognostic groups with significant survival differences (log-rank p&lt;0.0001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This predictive model integrates routinely available clinical parameters to accurately stratify mortality and cardiovascular risk in ANOCA patients, providing a potential valuable decision-support tool for personalised therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-092614","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T07:15:25Z","timestamp":1746602125000},"page":"e092614","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Development and validation of a risk prediction model for adverse outcomes in patients with suspected coronary artery disease and no significant stenosis on angiography: a retrospective cohort study"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6089-4251","authenticated-orcid":false,"given":"Lei","family":"Zhu","sequence":"first","affiliation":[{"name":"Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng-Kai","family":"Xue","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Wu","sequence":"additional","affiliation":[{"name":"Institute for Global Health Sciences, University of California San Francisco, San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JingKun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Institute, University of California San Francisco, San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Tao","family":"Hu","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Kun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-Shu","family":"Gu","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Woon","family":"Rha","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Korea University Guro Hospital, Guro-gu, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang-Yin","family":"Chen","sequence":"additional","affiliation":[{"name":"Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"key":"2025121602421581000_15.5.e092614.1","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2016-310905"},{"key":"2025121602421581000_15.5.e092614.2","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000001052"},{"key":"2025121602421581000_15.5.e092614.3","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001168"},{"key":"2025121602421581000_15.5.e092614.4","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e3182776f83"},{"key":"2025121602421581000_15.5.e092614.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907272"},{"key":"2025121602421581000_15.5.e092614.6","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2019-315042"},{"key":"2025121602421581000_15.5.e092614.7","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jacc.2023.06.043","article-title":"Comprehensive Management of ANOCA, Part 1\u2014Definition, Patient Population, and Diagnosis","volume":"82","author":"Samuels","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2025121602421581000_15.5.e092614.8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.609990"},{"key":"2025121602421581000_15.5.e092614.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2022.09.047"},{"key":"2025121602421581000_15.5.e092614.10","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/j.jacc.2022.03.385","article-title":"Safety of Provocative Testing With Intracoronary Acetylcholine and Implications for Standard Protocols","volume":"79","author":"Takahashi","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2025121602421581000_15.5.e092614.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1415516"},{"key":"2025121602421581000_15.5.e092614.12","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/jamacardio.2023.2614","article-title":"Deferred Testing in Stable Outpatients With Suspected Coronary Artery Disease: A Prespecified Secondary Analysis of the PRECISE Randomized Clinical Trial","volume":"8","author":"Udelson","year":"2023","journal-title":"JAMA Cardiol"},{"key":"2025121602421581000_15.5.e092614.13","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001029"},{"key":"2025121602421581000_15.5.e092614.14","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz425"},{"key":"2025121602421581000_15.5.e092614.15","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.j1194","article-title":"Prognosis of undiagnosed chest pain: linked electronic health record cohort study","volume":"357","author":"Jordan","year":"2017","journal-title":"BMJ"},{"key":"2025121602421581000_15.5.e092614.16","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr331"},{"key":"2025121602421581000_15.5.e092614.17","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.50"},{"key":"2025121602421581000_15.5.e092614.18","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1001\/jamacardio.2016.5501","article-title":"Identification of Patients With Stable Chest Pain Deriving Minimal Value From Noninvasive Testing: The PROMISE Minimal-Risk Tool, A Secondary Analysis of a Randomized Clinical Trial","volume":"2","author":"Fordyce","year":"2017","journal-title":"JAMA Cardiol"},{"key":"2025121602421581000_15.5.e092614.19","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015515","article-title":"Soluble Urokinase-Type Plasminogen Activator Receptor and High-Sensitivity Troponin Levels Predict Outcomes in Nonobstructive Coronary Artery Disease","volume":"9","author":"Al-Badri","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2025121602421581000_15.5.e092614.20","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10554-021-02429-3","article-title":"Major adverse cardiac events in symptomatic women with non-obstructive CAD on coronary CTA: pooled analysis from PROMISE and SCOT-HEART","volume":"38","author":"Mansour","year":"2022","journal-title":"Int J Cardiovasc Imaging"},{"key":"2025121602421581000_15.5.e092614.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.04.002"},{"key":"2025121602421581000_15.5.e092614.22","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013234","article-title":"Predicted Versus Observed Major Adverse Cardiac Event Risk in Women With Evidence of Ischemia and No Obstructive Coronary Artery Disease: A Report From WISE (Women\u2019s Ischemia Syndrome Evaluation)","volume":"9","author":"Sedlak","year":"2020","journal-title":"JAHA"},{"key":"2025121602421581000_15.5.e092614.23","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g7594","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"350","author":"Collins","year":"2015","journal-title":"BMJ"},{"key":"2025121602421581000_15.5.e092614.24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.024534"},{"key":"2025121602421581000_15.5.e092614.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.08.1038"},{"key":"2025121602421581000_15.5.e092614.26","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000211"},{"key":"2025121602421581000_15.5.e092614.27","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl040"},{"key":"2025121602421581000_15.5.e092614.28","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.14681"},{"key":"2025121602421581000_15.5.e092614.29","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.4.477"},{"key":"2025121602421581000_15.5.e092614.30","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)00519-V"},{"key":"2025121602421581000_15.5.e092614.31","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)00507-M"},{"key":"2025121602421581000_15.5.e092614.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(01)01424-2"},{"key":"2025121602421581000_15.5.e092614.33","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.116.003863","article-title":"Ten-Year Mortality in the WISE Study (Women\u2019s Ischemia Syndrome Evaluation)","volume":"10","author":"Kenkre","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2025121602421581000_15.5.e092614.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.03.015"},{"key":"2025121602421581000_15.5.e092614.35","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.jacc.2023.06.044","article-title":"Comprehensive Management of ANOCA, Part 2\u2014Program Development, Treatment, and Research Initiatives","volume":"82","author":"Smilowitz","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2025121602421581000_15.5.e092614.36","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(97)00225-3"},{"key":"2025121602421581000_15.5.e092614.37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/MCA.0000000000000598","article-title":"Anemia and coronary artery disease: pathophysiology, prognosis, and treatment","volume":"29","author":"Rymer","year":"2018","journal-title":"Coron Artery Dis"},{"key":"2025121602421581000_15.5.e092614.38","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.029689","article-title":"Causal Association Between Anemia and Cardiovascular Disease: A 2-Sample Bidirectional Mendelian Randomization Study","volume":"12","author":"Gan","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2025121602421581000_15.5.e092614.39","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000052622.51963.FC"},{"key":"2025121602421581000_15.5.e092614.40","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.223"},{"key":"2025121602421581000_15.5.e092614.41","doi-asserted-by":"crossref","DOI":"10.1186\/s12902-022-00954-3","article-title":"Elevated blood urea nitrogen-to-creatinine ratio increased the risk of Coronary Artery Disease in patients living with type 2 diabetes mellitus","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"2025121602421581000_15.5.e092614.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.02.068"},{"key":"2025121602421581000_15.5.e092614.43","first-page":"999","article-title":"Risk of Cardiovascular Mortality Associated With Serum Sodium and Chloride in the General Population","volume":"34","author":"He","year":"2018","journal-title":"Can J Cardiol"},{"key":"2025121602421581000_15.5.e092614.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2015.07.008"},{"key":"2025121602421581000_15.5.e092614.45","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/jgs.13937","article-title":"Association Between Small Decrease in Serum Sodium Concentration within the Normal Range and All-Cause and Cardiovascular Mortality in Elderly Adults over 5 Years","volume":"64","author":"Ahn","year":"2016","journal-title":"J Am Geriatr Soc"},{"key":"2025121602421581000_15.5.e092614.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2008.11.033"},{"key":"2025121602421581000_15.5.e092614.47","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.330.7492.625"},{"key":"2025121602421581000_15.5.e092614.48","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.HYP.0000216794.24161.8c","article-title":"Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failure","volume":"47","author":"McKie","year":"1979","journal-title":"Hypertens Dallas Tex"},{"key":"2025121602421581000_15.5.e092614.49","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031994"},{"key":"2025121602421581000_15.5.e092614.50","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn525"},{"key":"2025121602421581000_15.5.e092614.51","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.13.1609"},{"key":"2025121602421581000_15.5.e092614.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2016.11.003"},{"key":"2025121602421581000_15.5.e092614.53","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)80348-9"},{"key":"2025121602421581000_15.5.e092614.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2010.10.029"},{"key":"2025121602421581000_15.5.e092614.55","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000140263.20897.42"},{"key":"2025121602421581000_15.5.e092614.56","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2115"},{"key":"2025121602421581000_15.5.e092614.57","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000001063"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-092614","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T10:42:23Z","timestamp":1765881743000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-092614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":57,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,6]]},"published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1136\/bmjopen-2024-092614"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-092614","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]}}}